Santhera Pharmaceuticals Holding AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Santhera Pharmaceuticals Holding AG with three other
pharmaceutical manufacturers in Europe:
sales of 31.69 million Norwegian Kroner [US$3.74 million]
of which 100%
was Vitamin K2/MenaQ7),
(3.48 million Euro [US$3.76 million]
of which 88%
was Orphan Products Oncology), and
based in Norway
(38.76 million Norwegian Kroner [US$4.58 million]
During the year ended December of 2015, sales at
Santhera Pharmaceuticals Holding AG were 4.32 million Swiss Francs (US$4.36 million).
increase of 66.8%
versus 2014, when the company's sales were 2.59 million Swiss Francs.